Quantcast

Latest Clinical research Stories

2014-09-10 20:24:21

LONDON, Sept. 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biotech API Manufacturing Services: World Industry and Market 2014-2024https://www.reportbuyer.com/product/2006105/Biotech-API-Manufacturing-Services-World-Industry-and-Market-2014-2024.html Report DetailsOutsourced biopharma production - new analysis announcing revenue prospectsWhat's the outlook for making biological active pharma ingredients (APIs) under contract? Visiongain's new report...

2014-09-10 16:26:51

Approval based on improved overall survival, delayed time to radiographic progression and an overall positive benefit-risk profile TOKYO and SAN FRANCISCO, Sept. 10, 2014 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN) announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for the use of XTANDI(®) (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer (CRPC). This new approved...

2014-09-10 12:30:29

DALLAS, September 10, 2014 /PRNewswire/ -- The report "Feed Testing Market by Livestock (Swine, Poultry, Pets, Equine, Cattle, and Aquatic animals), by Type (Mycotoxin, Pathogen, Nutritional Labeling, Crop Chemicals, Fats & Oils, and Others), & Geography - Global Trends & Forecasts to 2019", defines and segments the Feed Testing Market with analyses and projection of the market size in terms of value and volume. It also identifies the driving and restraining...

2014-09-10 12:28:22

WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The following is a statement on behalf of RetireSafe: Dear Member of Congress; We write to you today to bring to your attention a critical safety issue that could affect all Americans, but especially those older Americans who rely on relatively new medicines called "biologics". RetireSafe, a 400,000-supporter strong nationwide advocacy organization for seniors, works hard to give a voice to retired Americans and those who hope to retire....

2014-09-10 12:27:57

NEW YORK, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech announced today the launch of ADDF ACCESS, a new and improved open access platform to connect scientists with a virtual network of contract research organizations (CROs), drug development experts and educational resources. By leveraging OnDeckBiotech's cutting-edge technology, the enhanced ADDF ACCESS platform will streamline links between researchers and CROs specializing...

2014-09-10 12:24:38

AMGEN, ASTRAZENECA AND CELGENE SHOW HIGHEST COMMITMENT TO TRANSPARENCY NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Citeline®, an Informa business unit, and the pharmaceutical industry's leading research authority on clinical trials, reported today that clinical trial transparency, also known as responsible data sharing, is in a much healthier state than shown in previous studies, when you refer to the right variety of sources. http://photos.prnewswire.com/prnvar/20120917/NE75453LOGO...

2014-09-10 08:30:43

New addition expands WCG's New England presence and increases its expertise in all phases of clinical research PRINCETON, N.J., Sept. 10, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that New England Independent Review Board (IRB) has joined the group of companies. Based near Boston, MA, New England IRB expands WCG's presence in the important New England clinical...

2014-09-10 08:30:06

YARDLEY, Pa., Sept. 10, 2014 /PRNewswire/ -- Since 1974 Mapi has lead Patient-Centred Research and pioneered industry wide innovations in Pharmaceutical Market Research, Cross-Cultural adaptation of Patient Reported Outcomes and Post-Approval pharmaceutical Research. Initiating global programs such as the ERIQA group; launch of the PRO Harmonization Group (which brings together the members of ERIQA, ISOQOL, ISPOR and the 'Health Outcomes Committee' of PhRMA, and the FDA) and...

2014-09-10 08:29:52

REDWOOD CITY, Calif., Sept. 10, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the publication of a pharmacoeconomic analysis of the cost of intravenous patient-controlled analgesia with opioids based on current literature and data from over 500 U.S. hospitals. The manuscript entitled 'Cost...

2014-09-09 23:13:43

Devicemakers can take the mystery out of complaint handling and MDR by attending the Complaint Handling and Medical Device Reporting On-Demand webinar. The presenter, noted legal expert Michael Heyl, has developed a compliance roadmap that saves time, money and headaches for device manufacturing companies. Falls Church, VA (PRWEB) September 09, 2014 Complaint Handling and Medical Device Reporting: Where Inspectors Look First **FDAnews On-Demand Webinar** Sept. 25, 2014 ● Any Time at...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related